January 2020 Archive UM Ventures News Partner News Hoth Therapeutics to Further its Research of VNLG-152 and Plans Exercise of its Option Agreement with University of Maryland, Baltimore and Isoprene Pharmaceuticals Inc.Wednesday, January 29, 2020 New Nanoparticle Therapy Appears More Effective Than Standard Therapy at Treating Aggressive Breast CancerThursday, January 16, 2020 UMB Begins Phase 3 of Novavax COVID-19 Vaccine TrialMonday, January 6, 2020